They will get cheaper with time as the techniques become commodities.
Absolutely not. Take mebendazole, for instance. It's generic, it's on the WHO's list of most-essential medicines, but in the US there is only a single manufacturer (Janssen/Johnson & Johnson) who uses their monopoly to charge an outrageous $350 per tablet. In every other nation, the price per tablet ranges from $0.10 to $10.00.
which is why we should have most favored nation status. for most drugs, it would probably raise prices globally rather than significantly lower them in the US.
given tropical diseases are so rare in the US though, there might not be enough liquidity to encourage good pricing
Comments
Absolutely not. Take mebendazole, for instance. It's generic, it's on the WHO's list of most-essential medicines, but in the US there is only a single manufacturer (Janssen/Johnson & Johnson) who uses their monopoly to charge an outrageous $350 per tablet. In every other nation, the price per tablet ranges from $0.10 to $10.00.
which is why we should have most favored nation status. for most drugs, it would probably raise prices globally rather than significantly lower them in the US.
given tropical diseases are so rare in the US though, there might not be enough liquidity to encourage good pricing